Skip to main content

Bacterial Genomics Firm Era7 Bioinformatics Receives $400K Investment

NEW YORK (GenomeWeb) – Era7 Bioinformatics today announced a $400,000 investment in the firm by Comercial Rafer to help accelerate the international expansion of the company.

Era7, which is based in Spain, said that it specifically wants to expand its operations in the US, where it has a subsidiary headquartered in Cambridge, Mass. It and Comercial Rafer have also reached a distribution agreement for Era7's services covering Spain and Portugal, Era7 CEO Eduardo Pareja said in a statement.

Era7 provides services focused on next-generation sequencing and bioinformatics for bacterial genomics and metagenomics. Comercial Rafer, also based in Spain, helps clinical and industrial R&D firms commercialize reagents and instruments.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.